Columbia Laboratories, Inc. is now Juniper Pharmaceuticals, Inc. and its Nottingham, UK based subsidiary, Molecular Profiles, Ltd., is now Juniper Pharma Services.

Juniper Pharmaceuticals is a specialty pharmaceutical company with a focus on women’s health. Its key product, Crinone (progesterone gel). Recent pipeline developments include an investigational new drug filing with the US Food and Drug Administration for COL-1077, a 10% lidocaine bioadhesive gel intended as an acute anesthetic for use in women undergoing transvaginal pipelle-directed endometrial biopsy. A Phase II randomized, double-blinded, placebo controlled study that will enroll 150 patients at fifteen U.S. sites will be initiated later this quarter.

The Company recently licensed worldwide exclusive rights to a proprietary intra-vaginal ring technology (IVR) developed by scientists Dr. Robert Langer from the Massachusetts Institute of Technology and Dr. William Crowley from Massachusetts General Hospital and Harvard Medical School. The IVR technology enables the delivery of one or more pharmaceuticals at different dosages and release rates in a single segmented ring. This patient administered-device will be utilized as a drug delivery platform for Juniper’s emerging proprietary product pipeline. Drs. Langer and Crowley are also serving as strategic scientific advisors to help guide Juniper’s R&D initiatives and drug development strategy.

Source: Juniper Pharmaceuticals